Synapse - Heiko Schoder

Results (132)

Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer

Journal Article

Meirelles, G. S. P.; Schoder, H.; Ravizzini, G. C.; Gonen, M.; Fox, J. J.; Humm, J.; Morris, M. J.; Scher, H. I.; Larson, S. M.
Clinical Cancer Research (2010)

Fulltext@MSK | Save

Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases

Journal Article

Jansen, J. F. A.; Schoder, H.; Lee, N. Y.; Wang, Y.; Pfister, D. G.; Fury, M. G.; Stambuk, H. E.; Humm, J. L.; Koutcher, J. A.; Shukla-Dave, A.
International Journal of Radiation Oncology, Biology, Physics (2010)

Fulltext@MSK | Save

Pharmacokinetic assessment of the uptake of 16β-18F-fluoro- 5α-dihydrotestosterone (FDHT) in prostate tumors as measured by PET

Journal Article

Beattie, B. J.; Smith-Jones, P. M.; Jhanwar, Y. S.; Schoder, H.; Ross Schmidtlein, C.; Morris, M. J.; Zanzonico, P.; Squire, O.; Meirelles, G. S. P.; Finn, R.; more...
Journal of Nuclear Medicine (2010)

Fulltext@MSK | Save

Correlation of dynamic contrast enhanced magnetic resonance imaging (DCE MRI) with (18)f-fluoromisonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) in assessing tumor hypoxia in a series of head and neck cancer (HNC) patients with nodal metastases

Meeting Abstract

Lee, N.; Jensen, J.; Schoder, H.; Wang, Y.; Fury, M.; Pfister, D. G.; Stambuk, H.; Humm, J.; Koutcher, J.; Shukla-Dave, A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Clinical utility of (18)F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer

Journal Article

Ong, S. C.; Schoder, H.; Lee, N. Y.; Patel, S. G.; Carlson, D.; Fury, M.; Pfister, D. G.; Shah, J. P.; Larson, S. M.; Kraus, D. H.
Journal of Nuclear Medicine (2008)

Fulltext@MSK | Save

Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy

Journal Article

Estilo, C. L.; Van Poznak, C. H.; Williams, T.; Bohle, G. C.; Lwin, P. T.; Zhou, Q.; Riedel, E. R.; Carlson, D. L.; Schoder, H.; Farooki, A.; more...
The Oncologist (2008)

Fulltext@MSK | Save

The probability of a positive bone scan in patients who were treated with adrogen ablasio therapy for rising PSA after radical prostatectomy

Meeting Abstract

Dotan, Z. A.; Sathyamoorthy, K.; Bianco, F. J.; Stephenson, A. J.; Eastham, J. A.; Fearn, P.; Schoder, H.; Scher, H. I.; Scardino, P. T.; Kattan, M. W.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

2-[ 18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy

Journal Article

Schoder, H.; Herrmann, K.; Gonen, M.; Hricak, H.; Eberhardt, S.; Scardino, P.; Scher, H. I.; Larson, S. M.
Clinical Cancer Research (2005)

Fulltext@MSK | Save

Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy

Journal Article

Dotan, Z. A.; Bianco, F. J. Jr; Rabbani, F.; Eastham, J. A.; Fearn, P.; Scher, H. I.; Kelly, K. W.; Chen, H. N.; Schoder, H.; Hricak, H.; more...
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

What is the probability of a positive bone scan (+BS) in patients with a rising PSA after radical prostatectomy (RP): A new nomogram

Meeting Abstract

Dotan, Z. A.; Kattan, M. W.; Bianco, F. J.; Rabbani, F.; Eastham, J. A.; Scher, H. I.; Chen, H. N.; Schoder, H.; Hricak, H.; Scardino, P. T.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save